KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Share-based Compensation (2018 - 2025)

Historic Share-based Compensation for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $32.2 million.

  • Progyny's Share-based Compensation fell 304.37% to $32.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $127.9 million, marking a year-over-year increase of 147.3%. This contributed to the annual value of $128.1 million for FY2024, which is 450.12% up from last year.
  • Latest data reveals that Progyny reported Share-based Compensation of $32.2 million as of Q3 2025, which was down 304.37% from $32.4 million recorded in Q2 2025.
  • Over the past 5 years, Progyny's Share-based Compensation peaked at $33.2 million during Q3 2024, and registered a low of $5.0 million during Q1 2021.
  • Its 5-year average for Share-based Compensation is $25.4 million, with a median of $30.8 million in 2023.
  • In the last 5 years, Progyny's Share-based Compensation soared by 38669.05% in 2022 and then plummeted by 304.37% in 2025.
  • Quarter analysis of 5 years shows Progyny's Share-based Compensation stood at $15.0 million in 2021, then surged by 95.21% to $29.3 million in 2022, then dropped by 1.7% to $28.8 million in 2023, then increased by 7.15% to $30.9 million in 2024, then grew by 4.26% to $32.2 million in 2025.
  • Its Share-based Compensation stands at $32.2 million for Q3 2025, versus $32.4 million for Q2 2025 and $32.5 million for Q1 2025.